The effect of intravitreal injection of bevacizumab after vitrectomy for proliferative diabetic retinopathy
Not Applicable
- Conditions
- proliferative diabetic retinopathy
- Registration Number
- JPRN-UMIN000009801
- Lead Sponsor
- Tokyo medical university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
It is IVB medication before an operation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method (1) Primary endpoint Frequency of postoperative vitreous body re-bleeding (2) Secondary endpoint A. Evaluation of the activity of the new blood vessel by the anterior ocular segment photograph and a fundus-of-the-eye photograph B. Evaluation of the activity of the new blood vessel by fluorescence fundus-of-the-eye imaging C. The improvement factor of eyesight D. The improvement factor of the thickness of the retina by an optical interference fault meter E. The improvement factor of intraocular pressure
- Secondary Outcome Measures
Name Time Method